Results 21 to 30 of about 23,433 (212)

Effectiveness and Safety of Short Course Liposomal Amphotericin B (AmBisome) as First Line Treatment for Visceral Leishmaniasis in Bangladesh [PDF]

, 2015
Bangladesh is one of the endemic countries for Visceral Leishmaniasis (VL). Médecins Sans Frontières (MSF) ran a VL treatment clinic in the most endemic district (Fulbaria) between 2010 and 2013 using a semi-ambulatory regimen for primary VL of 15mg/kg ...
Akter, Fatima, Asad, Asaduzzam, Collin, Simon M, Gomes, Sujit, Kumar Das, Asish, Lucero, Emiliano, Ritmeijer, Koert   +6 more
core   +13 more sources

Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report [PDF]

, 2001
Background Mucormycosis (or zygomycosis) is the term for infection caused by fungi of the order Mucorales. Mucoraceae may produce severe disease in susceptible individuals, notably patients with diabetes and leukemia.
MG Rinaldi, R Koçak, D Selcen, S Maury, AM Sugar, NA Parfrey, KK Lim, M Ericsson, HA Gallis, F Meunier, J Brajtburg, H Funada, AE Moses, S Kline, TJ Walsh   +14 more
core   +2 more sources

Low castes have poor access to visceral leishmaniasis treatment in Bihar, India [PDF]

, 2012
Objectives  Bihar, the poorest state in India, concentrates most of the visceral leishmaniasis (VL) cases in the country. A large proportion of the poor rural communities where VL is endemic are marginalized by their socio-economic status, intrinsically ...
Alvar, Babu, Barratt, Boelaert, Cerf, Collin, de Onis, Dedet, Desjeux, Dye, Hasker, Heymann, India., G.o, Mondal, Ostyn, Ranjan, Sinha, Thakur, Van de Poel, WHO, WHO, WHO, WHO/UNICEF   +22 more
core   +2 more sources

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

Medical Mycology Case Reports, 2017
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi, Yuta Katayama, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Shinya Katsutani, Koji Iwato, Hideki Asaoku   +8 more
doaj   +1 more source

Potency and stability of liposomal Amphotericin B formulated for topical management of Aspergillus spp. infections in burn patients

Burns Open, 2020
Background: Systemic fungal infections are an important mortality factor when considering severely burned patients. Preventive topical pharmacotherapeutic management of deep fungal infections remains of secondary concern when initially treating a burn ...
Alexis Laurent, Olivier Pantet, Lydie Laurent, Nathalie Hirt-Burri, Anthony de Buys Roessingh, Wassim Raffoul, Philippe Laurent, Michel Monod, Lee Ann Applegate   +8 more
doaj   +1 more source

Management of trypanosomiasis and leishmaniasis [PDF]

, 2012
<p>Background: The current treatments for human African trypanosomiasis (HAT), Chagas disease and leishmaniasis (collectively referred to as the kinetoplastid diseases) are far from ideal but, for some, there has been significant recent progress ...
Alsford, Alvar, Alvar, Barrett, Barrett, Ben Salah, Berman, Bern, Brun, Brun, Burri, Chappuis, Coura, Croft, Croft, El-Sayed, Frearson, Hailu, Jacobs, Jacobs, Le Loup, Lessa, M. P. Barrett, Miranda-Verastegui, Paine, Pinazo, Priotto, Rassi, Reithinger, Rodgers, S. L. Croft, Stuart, Sundar, Sundar, Sundar, Sundar, Torreele, Vanhollebeke, Vincent, Voogd   +39 more
core   +2 more sources

Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil

Revista da Sociedade Brasileira de Medicina Tropical, 2019
INTRODUCTION: Visceral leishmaniasis (VL) is fatal if not diagnosed and treated. This study aimed to estimate the cost-effectiveness of diagnostic-therapeutic alternatives for VL in Brazil.
Tália Santana Machado de Assis, Ana Rabello, Gláucia Cota, Guilherme Loureiro Werneck, André Luís Ferreira de Azeredo-da-Silva   +4 more
doaj   +1 more source

HIV-associated disseminated histoplasmosis successfully treated with isavuconazole consolidation therapy

Medical Mycology Case Reports, 2020
A 30-year-old man with advanced HIV and disseminated histoplasmosis deteriorated after stepping down from intravenous liposomal amphotericin B to itraconazole.Therapeutic levels of itraconazole and posaconazole were not achieved, therefore liposomal ...
Andrea Mazzella, Neil R.H. Stone, Erica R.M. Pool, Ana García Mingo, Sorina Bolache, Chris Wood   +5 more
doaj   +1 more source

Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. [PDF]

, 2009
OBJECTIVE: To identify risk factors for in-hospital mortality in patients treated for visceral leishmaniasis (VL) in Uganda. METHODS: Retrospective analysis of VL patients' clinical data collected for project monitoring by Médecins Sans Frontières in ...
Bern, Bryceson, Chappuis, Collin, Croft, Delgado, Desjeux, Guerin, Jamjoom, Lyons, Moore, Mueller, Mueller, Olliaro, Ritmeijer, Ritmeijer, Seaman, Sundar, Thakur, Veeken, WHO   +20 more
core   +3 more sources

Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report

Revista da Sociedade Brasileira de Medicina Tropical, 2019
In Brazil, meglumine antimoniate is the first drug of choice for mucosal leishmaniasis treatment followed by amphotericin B and pentamidine isethionate.
Benivaldo Ramos Ferreira Terceiro, Tania Salgado de Souza Torraca, Frederico Pereira Bom Braga, Ana Cristina da Costa Martins, Lucia Regina Brahim, Mauricio Naoto Saheki, Luciana de Freitas Campos Miranda, Armando de Oliveira Schubach, Cláudia Maria Valete-Rosalino   +8 more
doaj   +1 more source